From OCBJ, May 22, 2023: Cartilage Inc., a biomedical startup from the University of California Irvine, is developing a product that will restore TMJ function by regenerating missing tissue and repairing defects in the jaw joint. (Page 16: Startups & Innovations)
From CIRM, April 27, 2023: The Board of the California Institute for Regenerative Medicine (CIRM) approved investing nearly $89 million in projects from its Clinical and Translation programs at its April meeting. Nearly $39 million will support four projects in the agency’s Clinical program, which speeds up support and provides funding for eligible stem cell and gene therapy-based projects through any stage of clinical trial activity. Included in the awards is a $6,000,000 grant to Kyriacos Athanasiou to perform IND-enabling studied for Hyaleon® for treatment of the TMJ disc complex.
From UCI Beall Applied Innovation News, March 31, 2021: "UC Irvine (UCI) startup Cartilage Inc., a Wayfinder team, recently received a $256,000 National Science Foundation (NSF) phase one Small Business Innovation Researcher (SBIR) grant. The funds will be used to develop their latest product, a special injectable cartilage glue designed to fix Cartilage’s and other commercially available implants and to help with the integration and healing of cartilage implants into surrounding tissues. This is the second SBIR grant the team has received in less than six months."
From UCI Beall Applied Innovation News, October 20, 2020: "UC Irvine startup Cartilage Inc., a Wayfinder team, recently received a Phase I $252,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The startup will use this grant to investigate the feasibility of their product Hyaleon®, a scaffold-free, tissue-engineered cartilage implant, capable of healing both large and small cartilage defects."